Phase II randomised placebo-controlled trial of sodium selenate as a disease-modifying treatment in chronic drug-resistant temporal lobe epilepsy: the SeLECT study protocol
Lucy Vivash, Hannah Johns, Leonid Churilov, Sara MacPhail, Pablo Casillas-Espinosa, Charles Malpas, Sandy R Shultz, Chris Tailby, Manori Wijayath, David Reutens, Lisa Gillinder, Piero Perucca, Patrick Carney, John-Paul Nicolo, Nicholas Lawn, Patrick Kwan, Dennis Velakoulis, Christopher M Hovens, Terence J O’Brien
BMJ Open Oct 2023, 13 (10) e075888; DOI: 10.1136/bmjopen-2023-075888
